ArticleMedicine2026
The genetic association between celiac disease and risk of functional dyspepsia: A Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Celiac disease (CeD) is a common autoimmune disease of the small intestine triggered by ingesting gluten-containing foods. Chronic symptoms are characteristic of functional dyspepsia (FD), including chronic epigastric pain and burning. The clinical and genetic overlap between FD and CeD is currently being investigated in a large-scale comorbidity and genetic predisposition study. In this study, causal connections between CeD and FD were evaluated using Mendelian randomization (MR) methods, including the inverse variance weighted, MR-Egger regression, and the weighted median methods. Cochran Q test was used to examine heterogeneity among the causal effects. MR-Egger regression indicates the average pleiotropic effect of instrumental variables. MR pleiotropy residual sum and outlier analysis was conducted to detect outlier instruments and remove pleiotropy. CeD was associated with a modestly increased risk of FD, with an estimated effect size of 3.2% (odds ratio = 1.032 [1.008-1.056], P = .019). The reverse MR analysis provided no significant evidence supporting a causal effect of FD on CeD risk (odds ratio = 1.173 [0.989-1.390], P = .099). In addition, no substantial heterogeneity or horizontal pleiotropy was detected in either the forward or reverse MR analyses. These findings highlight the need for routine FD screening among patients with CeD and indicate that optimizing CeD management may help reduce the burden of FD in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.